Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    Leukemia & lymphoma · 2022
    DCDavid C HelfgottSRSabrina Racine-BrzostekZZZhen ZhaoPJPaul J Christos+3 more →GJGail J Roboz
    PMID: 36282213DOIFirst author3 citations

Publications

13 publications

Clinical research

2 studies

Active

1 study
  • PI
    An Interventional Phase 3, Open-label, Two-cohort Study to Investigate the Efficacy and Safety of Fosmanogepix in Adult Patients With Invasive Mold Infections Caused by Aspergillus Spp., Fusarium Spp., Lomentospora Prolificans, Mucorales Fungi, or Other Multidrug Resistant Molds
    PHASE3 · Basilea Pharmaceutica, Ltd. · OPEN TO ACCRUAL (as of 2026)
    Invasive Mold Infections
    NCT06925321
Completed & closed trials (1)
  • PI
    SPIND 175575 - fosmanogepix
    Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2026)